Yestar Healthcare Holdings Company Limited
[Yestar 2393.HK] Fujifilm Becomes A Strategic Partner of Yestar Healthcare By Investing Not Less than HK$411.7 Million
Yestar Healthcare Holdings Company Limited Fujifilm Becomes A Strategic Partner of Yestar Healthcare Co-exploring Opportunities Along the Value Chain of Medical Industry Fujifilm is a pioneer, a renowned innovator and market leader in medical diagnostic field. Leveraging on its proprietary technologies and strong research and development capabilities, Fujifilm now conducts business in a diverse range of healthcare field covering medical imaging and diagnostics equipment, pharmaceuticals, bio CDMO, and regenerative medicine. Yestar, on the other hand, has also been a dedicated player in the healthcare and medical sector. As a successful medical consumable distribution platform and service provider, Yestar has an extensive network that covers all the first-tier cities and most of the affluent regions in the People’s Republic of China (the “PRC”). In addition, in 2017, Yestar has taken one-step further to venture the independent clinical laboratory market, extending its presence in the healthcare sector. Together, by integrating complementary resources, the two partners will be capable to co-develop new products, co-offer new services along the value chain of the medical industry in the PRC. In response to collaboration, Mr. Teiichi Goto, the Director, Senior Vice President and General Manager of Medical Systems Business Division of FUJIFILM Corporation commented, “We are happy to further deepen our relationship with Yestar, our long-term and trust-worthy partner to co-develop the fast-growing medical industry market in the PRC. Through our strategic collaboration with Yestar and leverage on the resources and network of both parties, we can make people’s lives better and enrich society through the technologies, products and services we provide.” In light of the promising partnership , Mr. James Hartono, the Chairman of Yestar Healthcare, stated, “We are honored to have Fujifilm to be our strategic partner, which demonstrated Fujifilm’s recognition towards our dedication and hard work in the past decade. With shared vision and value, we believe we can create synergies and explore untapped market. Combining the distribution empire we have built, the technological competency of Fujifilm and the well-established reputations we both share in the medical industry in the PRC, we are confident that we are proficient to consolidate our presence in the market and bring fruitful results to our stakeholders. In the near future, we will continue on our network expansion journey and are open for any beneficial investment opportunity, merger and acquisition opportunities to refine our profitability and deliver promising results to our shareholders.” About Yestar Healthcare Holdings Company Limited This press release is issued by DLK Advisory Limited on behalf of Yestar Healthcare Holdings Company Limited. For enquiries, please contact: DLK Advisory Document: http://n.eqs.com/c/fncls.ssp?u=HMDMPGLQFH Document title: [Yestar 2393.HK] Strategic Investment Agreement
30/11/2018 Dissemination of a Financial Press Release, transmitted by EQS Group. |